vs

Side-by-side financial comparison of IT TECH PACKAGING, INC. (ITP) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

IT TECH PACKAGING, INC. is the larger business by last-quarter revenue ($25.6M vs $17.6M, roughly 1.5× AVITA Medical, Inc.). IT TECH PACKAGING, INC. runs the higher net margin — -5.7% vs -66.0%, a 60.3% gap on every dollar of revenue. On growth, IT TECH PACKAGING, INC. posted the faster year-over-year revenue change (2.1% vs -4.3%). IT TECH PACKAGING, INC. produced more free cash flow last quarter ($1.5M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 10.5%).

IT TECH PACKAGING, INC. is a paper manufacturing enterprise primarily operating in China. It produces and distributes a diverse portfolio of paper products including corrugated packaging paper, boxboard, and printing-use cultural paper, serving sectors such as consumer goods packaging, logistics, and commercial printing across its core market.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

ITP vs RCEL — Head-to-Head

Bigger by revenue
ITP
ITP
1.5× larger
ITP
$25.6M
$17.6M
RCEL
Growing faster (revenue YoY)
ITP
ITP
+6.4% gap
ITP
2.1%
-4.3%
RCEL
Higher net margin
ITP
ITP
60.3% more per $
ITP
-5.7%
-66.0%
RCEL
More free cash flow
ITP
ITP
$7.6M more FCF
ITP
$1.5M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
10.5%
ITP

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ITP
ITP
RCEL
RCEL
Revenue
$25.6M
$17.6M
Net Profit
$-1.4M
$-11.6M
Gross Margin
7.9%
81.2%
Operating Margin
-3.9%
-59.1%
Net Margin
-5.7%
-66.0%
Revenue YoY
2.1%
-4.3%
Net Profit YoY
26.6%
-0.3%
EPS (diluted)
$-0.11
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ITP
ITP
RCEL
RCEL
Q4 25
$17.6M
Q3 25
$25.6M
$17.1M
Q2 25
$24.8M
$18.4M
Q1 25
$10.9M
$18.5M
Q4 24
$17.6M
$18.4M
Q3 24
$25.1M
$19.5M
Q2 24
$26.2M
$15.2M
Q1 24
$6.9M
$11.1M
Net Profit
ITP
ITP
RCEL
RCEL
Q4 25
$-11.6M
Q3 25
$-1.4M
$-13.2M
Q2 25
$-2.0M
$-9.9M
Q1 25
$-3.5M
$-13.9M
Q4 24
$-4.0M
$-11.6M
Q3 24
$-2.0M
$-16.2M
Q2 24
$-77.7K
$-15.4M
Q1 24
$-3.7M
$-18.7M
Gross Margin
ITP
ITP
RCEL
RCEL
Q4 25
81.2%
Q3 25
7.9%
81.3%
Q2 25
5.1%
81.2%
Q1 25
0.8%
84.7%
Q4 24
6.3%
87.6%
Q3 24
7.6%
83.7%
Q2 24
12.4%
86.1%
Q1 24
5.8%
86.4%
Operating Margin
ITP
ITP
RCEL
RCEL
Q4 25
-59.1%
Q3 25
-3.9%
-53.6%
Q2 25
-7.1%
-60.5%
Q1 25
-31.0%
-63.9%
Q4 24
-21.5%
-54.1%
Q3 24
-5.8%
-70.6%
Q2 24
2.1%
-102.8%
Q1 24
-51.0%
-155.0%
Net Margin
ITP
ITP
RCEL
RCEL
Q4 25
-66.0%
Q3 25
-5.7%
-77.3%
Q2 25
-7.9%
-53.9%
Q1 25
-32.2%
-74.9%
Q4 24
-22.9%
-63.0%
Q3 24
-7.9%
-82.9%
Q2 24
-0.3%
-101.3%
Q1 24
-54.6%
-168.0%
EPS (diluted)
ITP
ITP
RCEL
RCEL
Q4 25
$-0.37
Q3 25
$-0.11
$-0.46
Q2 25
$-0.16
$-0.38
Q1 25
$-0.35
$-0.53
Q4 24
$-0.40
$-0.44
Q3 24
$-0.20
$-0.62
Q2 24
$-0.01
$-0.60
Q1 24
$-0.37
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ITP
ITP
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$18.2M
Total DebtLower is stronger
$4.7M
Stockholders' EquityBook value
$152.0M
$-16.6M
Total Assets
$175.7M
$56.4M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ITP
ITP
RCEL
RCEL
Q4 25
$18.2M
Q3 25
$23.3M
Q2 25
$15.7M
Q1 25
$25.8M
Q4 24
$35.9M
Q3 24
$44.4M
Q2 24
$54.1M
Q1 24
$68.2M
Total Debt
ITP
ITP
RCEL
RCEL
Q4 25
Q3 25
$4.7M
Q2 25
$4.7M
Q1 25
$4.7M
Q4 24
$4.7M
Q3 24
$8.9M
Q2 24
$11.3M
Q1 24
$11.4M
Stockholders' Equity
ITP
ITP
RCEL
RCEL
Q4 25
$-16.6M
Q3 25
$152.0M
$-6.7M
Q2 25
$152.3M
$-12.9M
Q1 25
$152.8M
$-4.6M
Q4 24
$156.1M
$4.5M
Q3 24
$164.3M
$12.2M
Q2 24
$163.5M
$23.9M
Q1 24
$164.3M
$32.6M
Total Assets
ITP
ITP
RCEL
RCEL
Q4 25
$56.4M
Q3 25
$175.7M
$63.7M
Q2 25
$175.2M
$58.1M
Q1 25
$175.2M
$69.6M
Q4 24
$177.5M
$79.7M
Q3 24
$190.0M
$81.1M
Q2 24
$191.4M
$87.8M
Q1 24
$177.5M
$97.4M
Debt / Equity
ITP
ITP
RCEL
RCEL
Q4 25
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.05×
Q2 24
0.07×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ITP
ITP
RCEL
RCEL
Operating Cash FlowLast quarter
$1.5M
$-5.4M
Free Cash FlowOCF − Capex
$1.5M
$-6.1M
FCF MarginFCF / Revenue
5.9%
-34.7%
Capex IntensityCapex / Revenue
0.0%
3.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.8M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ITP
ITP
RCEL
RCEL
Q4 25
$-5.4M
Q3 25
$1.5M
$-5.2M
Q2 25
$1.4M
$-10.2M
Q1 25
$-2.5M
$-10.3M
Q4 24
$3.5M
$-8.1M
Q3 24
$1.5M
$-7.2M
Q2 24
$721.9K
$-12.8M
Q1 24
$624.4K
$-20.9M
Free Cash Flow
ITP
ITP
RCEL
RCEL
Q4 25
$-6.1M
Q3 25
$1.5M
$-6.2M
Q2 25
$1.3M
$-10.8M
Q1 25
$-2.5M
$-10.5M
Q4 24
$3.5M
$-9.7M
Q3 24
$1.2M
$-11.0M
Q2 24
$668.3K
$-15.4M
Q1 24
$615.4K
$-22.0M
FCF Margin
ITP
ITP
RCEL
RCEL
Q4 25
-34.7%
Q3 25
5.9%
-36.1%
Q2 25
5.4%
-58.4%
Q1 25
-22.8%
-56.9%
Q4 24
19.6%
-52.7%
Q3 24
4.9%
-56.1%
Q2 24
2.5%
-101.6%
Q1 24
9.0%
-198.2%
Capex Intensity
ITP
ITP
RCEL
RCEL
Q4 25
3.8%
Q3 25
0.0%
5.5%
Q2 25
0.1%
2.8%
Q1 25
0.1%
1.2%
Q4 24
0.1%
8.8%
Q3 24
1.0%
19.2%
Q2 24
0.2%
17.5%
Q1 24
0.1%
10.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons